BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4749248)

  • 1. [Treatment of schizophrenic states with a new long-acting tranquilizer].
    Buisson JF
    Ann Med Psychol (Paris); 1973 Feb; 2(2):287-93. PubMed ID: 4749248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapeutic effect of sordinol and fluanxol in the treatment of schizophrenic patients].
    Kontsevoi VA; Panteleeva GP; Zavidovskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1238-43. PubMed ID: 5370166
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of a new neuroleptic derivative: flupentixo flupentixol, in hypochondriac depression].
    Ledjri H; Fournel M
    Tunis Med; 1973; 51(2):107-11. PubMed ID: 4784401
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: A case of schizophrenia treated with flupenthixol (Depixol) injections.
    Guest RS; Perinpanayagam MS
    Br J Psychiatry; 1974 Jun; 124(0):617. PubMed ID: 4852666
    [No Abstract]   [Full Text] [Related]  

  • 6. The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol.
    Carney MW; Sheffield BF
    Curr Med Res Opin; 1973; 1(7):423-6. PubMed ID: 4203952
    [No Abstract]   [Full Text] [Related]  

  • 7. Flupenthixol decanoate in schizophrenia.
    Trueman HR; Valentine MG
    Br J Psychiatry; 1974 Jan; 124(578):58-9. PubMed ID: 4822414
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine, a novel major tranquilizer. Clinical experiences and pharmacotherapeutic hypotheses.
    de Maio D
    Arzneimittelforschung; 1972 May; 22(5):919-23. PubMed ID: 5068211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with Fluanxol-depot ampules in the treatment of patients with chronic psychoses].
    Schwalbe W
    Z Allgemeinmed; 1971 Dec; 47(36):1919-22. PubMed ID: 5142254
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of depression in general parctice: a controlled trial of flupenthixol ('Fluanxol').
    Frolund F
    Curr Med Res Opin; 1974; 2(2):78-89. PubMed ID: 4597572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine in long-term therapy of chronic schizophrenia].
    Gross H; Langner E; Pfolz H
    Arzneimittelforschung; 1974 Jul; 24(7):987-9. PubMed ID: 4408041
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy of schizophrenia.
    Klerman GL
    Annu Rev Med; 1974; 25(0):199-217. PubMed ID: 4152997
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of flupenthixol (emergil)].
    Bourgeois M
    Ann Med Psychol (Paris); 1971 Mar; 1(3):434-43. PubMed ID: 5558678
    [No Abstract]   [Full Text] [Related]  

  • 15. Simplified symptom registration in psychiatric trials: a statistical approach.
    Hansen V; Hagen AS; Lehmann EH; Astrup C
    Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold].
    Haase HJ; Frank T; Knaack M; Lehnhardt C; Richter-Peill H
    Nervenarzt; 1968 Jun; 39(6):275-9. PubMed ID: 5712433
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational use of psychotropic drugs. III. Major tranquilizers.
    Greenblatt DJ; Shader RI
    Am J Hosp Pharm; 1974 Dec; 31(12):1226-31. PubMed ID: 4156455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.